Taysha Gene Therapies, Inc. (TSHA)
4.445
+0.06
(+1.25%)
USD |
NASDAQ |
Oct 07, 16:00
4.445
0.00 (0.00%)
After-Hours: 18:40
Taysha Gene Therapies EPS Diluted (Quarterly) : -0.1264 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1264 |
| March 31, 2026 | -0.1157 |
| December 31, 2025 | -0.0977 |
| September 30, 2025 | -0.0926 |
| June 30, 2025 | -0.0902 |
| March 31, 2025 | -0.0799 |
| December 31, 2024 | -0.0917 |
| September 30, 2024 | -0.0953 |
| June 30, 2024 | -0.0899 |
| March 31, 2024 | -0.104 |
| December 31, 2023 | 0.2554 |
| September 30, 2023 | -0.9315 |
| June 30, 2023 | -0.3829 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2786 |
| December 31, 2022 | -0.9882 |
| September 30, 2022 | -0.648 |
| June 30, 2022 | -0.8493 |
| March 31, 2022 | -1.318 |
| December 31, 2021 | -1.322 |
| September 30, 2021 | -1.347 |
| June 30, 2021 | -1.092 |
| March 31, 2021 | -0.8657 |
| December 31, 2020 | -0.4851 |
| September 30, 2020 | -1.282 |
| June 30, 2020 | -0.5736 |
| March 31, 2020 | -0.1438 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.1231 |
| Protalix Biotherapeutics, Inc. | 0.0458 |
| Humacyte, Inc. | -0.1572 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.64M |
| Total Expenses (Quarterly) | 46.64M |
| Enterprise Value | 1.030B |
| Earnings Yield | -9.73% |
| Normalized Earnings Yield | -9.388 |